Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,157 public trials 307 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

Study of CAR-T Therapy in Older Patients

NCT04300998

Conditions: Blood Protein Disorders, Cardiovascular Diseases, DLBCL NOS, +19 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype

NCT06522737

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: Universitair Ziekenhuis Gent (UZ Gent) Ghent, Belgium

UZ Leuven - Gasthuisberg Campus Leuven, Belgium

Vseobecna fakultni nemocnice Prague, Czechia

Aarhus University Hospital Aarhus, Denmark

View all 44 locations

View Trial Details

Recruiting

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

NCT05544968

Conditions: CD30+ Anaplastic Large Cell Lymphoma, CD30+ Immunoblastic Large T-Cell Cutaneous Lymphoma, CD30+ Pleomorphic Large T-Cell Cutaneous Lymphoma, +19 more
Locations: Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Recruiting

Survivors Uniting for Remote Guided Exercise

NCT07290309

Conditions: Adnexal Diseases, Behavior, Blood Protein Disorders, +50 more
Locations: Human Performance Clinical Research Lab Fort Collins, Colorado, United States

View Trial Details

Recruiting

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

NCT06915246

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
Locations: City of Hope Phoenix Goodyear, Arizona, United States

City of Hope National Medical Center Duarte, California, United States

City of Hope Atlanta Newnan, Georgia, United States

City of Hope Chicago Zion, Illinois, United States

View Trial Details

Recruiting

RGL-305+ Lymphoma + Exploratory Clinical Study

NCT07006012

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

NCT04830137

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +36 more
Locations: City of Hope Duarte, California, United States

University of California Irvine Orange, California, United States

University of California San Francisco Medical Center San Francisco, California, United States

Sarah Cannon Research Institute at Colorado Blood Cancer Institute Denver, Colorado, United States

View all 16 locations

View Trial Details

Recruiting

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

NCT06859424

Conditions: AML (Acute Myelogenous Leukemia), Acute Leukemia (Category), Acute Lymphoid Leukemia (ALL), +36 more
Locations: University of Alabama Birmingham Birmingham, Alabama, United States

City of Hope Duarte, California, United States

Stanford Palo Alto, California, United States

University of Miami Miami, Florida, United States

View all 13 locations

View Trial Details

Recruiting

Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma

NCT05294367

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)

NCT07472972

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Universityhospital Zurich, Department of Medical Oncology and Hematology Zurich, Canton of Zurich, Switzerland

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions